CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

TRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms

IPO/OfferingPositive
AI Analysis

Summary

TRexBio and Retension Pharmaceuticals are completing IPOs raising $161.7M combined, bringing 2026 biotech IPO count to 29. City Therapeutics and Iambic Therapeutics have set proposed offering terms.

Importance:6/10
Sentiment:
0.60
IPOCapital_RaiseBiotech_Rebound
Related Companies

Read the original article

Published by BioSpace on October 9, 2026 1:33 PM

Read Original